Abbisko Cayman's Liver Cancer Drug Gets US FDA Orphan Drug Designation
Abbisko Cayman's Liver Cancer Drug Gets US FDA Orphan Drug Designation
Abbisko Cayman 的肝癌藥物獲得美國 FDA 孤兒藥稱號
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊